Accelerated partner therapy (APT) partner notification for people with
RCT
STIs
accelerated partner therapy
chlamydia
partner notification
transmission
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
29 03 2020
29 03 2020
Historique:
entrez:
2
4
2020
pubmed:
2
4
2020
medline:
17
2
2021
Statut:
epublish
Résumé
Partner notification (PN) is a process aiming to identify, test and treat the sex partners of people (index patients) with sexually transmitted infections (STIs). Accelerated partner therapy (APT) is a PN method whereby healthcare professionals assess sex partners, by telephone consultation, before giving the index patient antibiotics and STI self-sampling kits to deliver to their sex partner(s). The Limiting Undetected Sexually Transmitted infections to RedUce Morbidity programme aims to determine the effectiveness of APT in heterosexual women and men with chlamydia and determine whether APT could affect This protocol describes a cross-over cluster randomised controlled trial of APT, offered as an additional PN method, compared with standard PN. The trial is accompanied by an economic evaluation, transmission dynamic modelling and a qualitative process evaluation involving patients, partners and healthcare professionals. Clusters are 17 sexual health clinics in areas of England and Scotland with contrasting patient demographics. We will recruit 5440 heterosexual women and men with chlamydia, aged ≥16 years.The primary outcome is the proportion of index patients testing positive for This protocol received ethical approval from London-Chelsea Research Ethics Committee (18/LO/0773). Findings will be published with open access licences. ISRCTN15996256.
Identifiants
pubmed: 32229523
pii: bmjopen-2019-034806
doi: 10.1136/bmjopen-2019-034806
pmc: PMC7170609
doi:
Banques de données
ISRCTN
['ISRCTN15996256']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e034806Subventions
Organisme : Department of Health
ID : RP-PG-0614-20009
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Sex Transm Infect. 2013 Feb;89(1):57-62
pubmed: 22683893
BMJ. 2017 Jun 14;357:j2817
pubmed: 28615179
Trials. 2011 Apr 20;12:100
pubmed: 21507237
Stat Med. 2007 Jan 30;26(2):274-89
pubmed: 16538700
PLoS Med. 2015 Jan 15;12(1):e1001777
pubmed: 25590331
Sex Transm Infect. 2015 Dec;91(8):548-54
pubmed: 26019232
Sex Transm Infect. 2012 Feb;88(1):21-6
pubmed: 21795290
BMJ. 2007 Feb 17;334(7589):354
pubmed: 17237298
Int J STD AIDS. 2009 Sep;20(9):603-6
pubmed: 19710331
Sex Transm Dis. 2018 Feb;45(2):132-137
pubmed: 29329181
Cochrane Database Syst Rev. 2013 Oct 03;(10):CD002843
pubmed: 24092529
Sex Transm Dis. 2009 Aug;36(8):478-89
pubmed: 19617871
Stat Methods Med Res. 2007 Jun;16(3):259-75
pubmed: 17621471
Health Technol Assess. 2014 Jan;18(2):1-100, vii-viii
pubmed: 24411488
Stat Med. 2008 Nov 29;27(27):5578-85
pubmed: 18646266
PLoS One. 2012;7(5):e37778
pubmed: 22662220
Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165
pubmed: 17311735
Int J STD AIDS. 2012 Oct;23(10):748-52
pubmed: 23104751
J Med Ethics. 2002 Oct;28(5):313-7
pubmed: 12356960
Int J STD AIDS. 2013 Apr;24(4):253-61
pubmed: 23970656
Sex Transm Infect. 2007 Jul;83(4):292-303
pubmed: 17050567